Retroviral vector integration occurs in preferred genomic targets of human bone marrow-repopulating cells

Increasing use of hematopoietic stem cells for retroviral vector-mediated gene therapy and recent reports on insertional mutagenesis in mice and humans have created intense interest to characterize vector integrations on a genomic level. We studied retrovirally transduced human peripheral blood prog...

Full description

Saved in:
Bibliographic Details
Main Authors: Maier-Laufs, Stephanie (Author) , Gentner, Bernhard Rudolf (Author) , Nagy, Katalin Zsuzsanna (Author) , Jauch, Anna (Author) , Benner, Axel (Author) , Naundorf, Sonja (Author) , Kuehlcke, Klaus (Author) , Schiedlmeier, Bernhard (Author) , Ho, Anthony Dick (Author) , Zeller, W. Jens (Author) , Frühauf, Stefan (Author)
Format: Article (Journal)
Language:English
Published: [15 March 2003]
In: Blood
Year: 2003, Volume: 101, Issue: 6, Pages: 2191-2198
ISSN:1528-0020
DOI:10.1182/blood-2002-02-0627
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1182/blood-2002-02-0627
Verlag, lizenzpflichtig, Volltext: https://www.sciencedirect.com/science/article/pii/S000649712057331X
Get full text
Author Notes:Stephanie Laufs, Bernhard Gentner, K. Zsuzsanna Nagy, Anna Jauch, Axel Benner, Sonja Naundorf, Klaus Kuehlcke, Bernhard Schiedlmeier, Anthony D. Ho, W. Jens Zeller, and Stefan Fruehauf
Description
Summary:Increasing use of hematopoietic stem cells for retroviral vector-mediated gene therapy and recent reports on insertional mutagenesis in mice and humans have created intense interest to characterize vector integrations on a genomic level. We studied retrovirally transduced human peripheral blood progenitor cells with bone marrow-repopulating ability in immune-deficient mice. By using a highly sensitive and specific ligation-mediated polymerase chain reaction (PCR) followed by sequencing of vector integration sites, we found a multitude of simultaneously active human stem cell clones 8 weeks after transplantation. Vector integrations occurred with significantly increased frequency into chromosomes 17 and 19 and into specific regions of chromosomes 6, 13, and 16, although most of the chromosomes were targeted. Preferred genomic target sites have previously only been reported for wild-type retroviruses. Our findings reveal for the first time that retroviral vector integration into human marrow-repopulating cells can be nonrandom (P = .000 37).
Item Description:Preblished online as Blood first edition paper, November 7, 2002
Gesehen am 10.12.2021
Physical Description:Online Resource
ISSN:1528-0020
DOI:10.1182/blood-2002-02-0627